Therefore 52% are positive. The Southern Company had 48 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Friday, July 28 by Jefferies. Jefferies has "Buy" rating and $115000 target. As per Friday, August 11, the company rating was maintained by Piper Jaffray. The rating was initiated by Janney Capital on Friday, December 11 with "Buy". Argus Research downgraded the stock to "Hold" rating in Friday, March 3 report. JP Morgan has "Overweight" rating and $925 target. The rating was downgraded by Stifel Nicolaus to "Hold" on Thursday, November 3.
(NASDAQ:AMZN). Moreover, Cognios Cap Ltd Llc has 0.12% invested in Amazon.com, Inc. About 2.10 million shares traded. The institutional investor held 151,300 shares of the real estate investment trusts company at the end of 2017Q2, valued at $6.16M, down from 168,250 at the end of the previous reported quarter. Amazon Com Inc now has $551.45 billion valuation. American Century Companies Inc. now owns 1,647,564 shares of the e-commerce giant's stock worth $1,460,631,000 after purchasing an additional 8,704 shares during the last quarter. When the stock was hovering around $1,000 it looked like it was encountering some resistance, but ultimately it broke through and as of the close on Wednesday was trading at more than $1,152 a share. Amazon.com, Inc. (NASDAQ:AMZN) has risen 37.41% since December 7, 2016 and is uptrending. It has outperformed by 20.71% the S&P500.
Among 50 analysts covering Amazon.com (NASDAQ:AMZN), 47 have Buy rating, 0 Sell and 3 Hold. Therefore 94% are positive. The firm earned "Overweight" rating on Thursday, June 16 by KeyBanc Capital Markets.
More notable recent Amazon.com, Inc. (NASDAQ:AMZN) rating on Wednesday, October 11. SunTrust maintained the shares of AMZN in report on Friday, July 24 with "Neutral" rating. (NASDAQ:AMZN) has "Outperform" rating given on Friday, August 28 by Cowen & Co. Canaccord Genuity maintained Amazon.com, Inc. (NASDAQ:AMZN) on Friday, October 27 with "Outperform" rating. UBS maintained it with "Buy" rating and $120000 target in Monday, July 17 report. WealthTrust Arizona LLC increased its holdings in shares of Amazon.com by 2.7% in the 2nd quarter. (NASDAQ:ULTA) earned "Hold" rating by Oppenheimer on Wednesday, August 23. The company presently has an average rating of "Buy" and a consensus price target of $1,219.02. The stock of Liberty Property Trust (NYSE:LPT) has "Outperform" rating given on Tuesday, December 13 by Wells Fargo. The company was maintained on Wednesday, June 21 by Robert W. Baird. Harding Loevner LP holds 0.77% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN) by 1.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The e-commerce giant reported $0.52 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $1.09 by ($0.57). AMZN's profit will be $944.47M for 146.98 P/E if the $1.96 EPS becomes a reality. TiVo Corporation earnings have risen with an annualized rate of 41% over the last 5 years.
White House: Dry Throat Caused Donald Trump Word Slurring; Exam Scheduled
Trump, I can state unequivocally, will be the healthiest individual ever elected to the presidency", Dr. Since then, seven more women have come forward with allegations of sexual misconduct against Franken.
Investors sentiment decreased to 1.36 in 2017 Q2. Its down 0.34, from 1.7 in 2017Q1. It is negative, as 64 investors sold AMZN shares while 542 reduced holdings. Harbour Capital Advisors LLC raised its position in Amazon.com by 100,947.5% in the second quarter. Eagle Capital Mgmt Ltd Company reported 3,499 shares or 2.02% of all its holdings. Community Retail Bank Na stated it has 14 shares or 0% of all its holdings. Amazon.com comprises about 1.1% of Wesbanco Bank Inc.'s portfolio, making the stock its 20th biggest position. (NASDAQ:AMZN) for 357 shares. (NASDAQ:AMZN). C M Bidwell & Assocs Ltd has 9,362 shares for 1.93% of their portfolio. Riverpoint Capital Mgmt Limited Liability stated it has 1.01% of its portfolio in Amazon.com, Inc.
(NASDAQ:AMZN) last issued its quarterly earnings data on Thursday, October 26th. Mechanics Fincl Bank Trust Department, California-based fund reported 1,559 shares. Pennsylvania holds 12,238 shares. Hedge funds and other institutional investors own 59.79% of the company's stock. Citigroup maintained Amazon.com, Inc. Legal General Group Inc Public Ltd Com has invested 0.22% of its portfolio in Monsanto Company (NYSE:MON). (NASDAQ:AMZN) for 75,576 shares. Employees Retirement Association Of Colorado accumulated 294,078 shares. Valley National Advisers holds 0.37% or 1,071 shares in its portfolio. Wallington Asset Management Ltd Liability holds 1,978 shares. After $0.52 actual earnings per share reported by Amazon.com, Inc. for the previous quarter, Wall Street now forecasts 276.92% EPS growth.
Investors sentiment decreased to 1.16 in 2017 Q2. Its down 0.34, from 1.7 in 2017Q1. 91 funds opened positions while 275 raised stakes. Deutsche Financial Bank Ag has 0% invested in Cempra, Inc. Segall Bryant & Hamill Limited Company reported 2.02% stake. (NASDAQ:CEMP) for 290,398 shares. Ardevora Asset Llp invested in 0.87% or 28,400 shares. Mark Asset Mngmt reported 32,834 shares. Cox Christopher K also sold $2.45 million worth of Facebook, Inc. Bogle Inv Management L P De has 684,718 shares. Ironwood Investment Counsel Ltd Company has invested 0.19% in Amazon.com, Inc. Amazon.com had a return on equity of 13.87% and a net margin of 1.74%. Blackrock has invested 0.18% in Monsanto Company (NYSE:MON). Cornerstone Advsr Inc has 1,046 shares for 0.03% of their portfolio. Bell Savings Bank holds 71,909 shares. (NASDAQ:CEMP) or 428,467 shares. The company has market cap of $15.13 billion. The Company's lead product candidate is solithromycin, which is in Phase III clinical trials developed in oral capsules, intravenous, and suspension formulations for the treatment of community-acquired bacterial pneumonia in adults and children, as well as for ophthalmic infections and other indications. The firm is also developing fusidic acid, an antibiotic, which is in Phase III clinical trials for the treatment of acute bacterial skin and skin structure infections.